Global Head of Healthcare
As Global Head of Healthcare, Anna leads the KPMG healthcare network of 5,000 professionals who provide Audit, Tax and Advisory services to healthcare organizations in more than 70 countries and territories around the world.
Anna is a trusted advisor to health leaders ranging from ministers of health, hospital CEOs and executives of payor organizations across six continents. She draws on more than 30 years of experience in diverse senior managerial, board, and consultancy roles in the sector. She understands the complex nature of the sector and brings not only a bold vision for the future of health but also the experience to execute on transformation initiatives.
Anna is the author of several KPMG International publications on topics that include organizational transformation, health equity, COVID19 recovery and resilience, value-based healthcare, out of hospital care provision, and technology-enabled care delivery systems. She is a well-regarded keynote speaker at international events covering topics that include healthcare system effectiveness and resilience, digital transformation and health equity. Anna sits on the Steering Committee of the Partnership Program on Healthcare System Sustainability and Resilience, a joint initiative of the World Economic Forum, London School of Economics, Philips, AstraZeneca, and KPMG.
Prior to her appointment as Global Head in 2020, Anna was Head of Healthcare for KPMG in the Netherlands, where she founded and grew the firm’s healthcare advisory business. In this role, she supervised a number of successful national and regional transformation programs based on design and implementation of new service delivery, reimbursement and governance models and physical infrastructures. Anna was also global lead for KPMG’s Care System Redesign proposition group, in this capacity she worked extensively with clients to transform and help futureproof care systems.
Before joining KPMG in 2011, Anna held senior-level positions at several hospitals and academic health sciences centers, where she led and executed transformations. As CEO of the Dutch Diagnosis Related-Groups (DRGs) and Pricing Office, Anna was a major force behind the adoption of DRG systems for providers and the introduction of a new national healthcare payment system.
Anna has a PhD in Economic Sciences from Erasmus University Rotterdam. She is fluent in English, French, German and Dutch.